Privacy Statement

This app (hereinafter the “App“) is provided by Bayer Consumer Care AG. (hereinafter “us” or “we”). For further information regarding the provider of the App, please refer to our imprint.

A.         Handling of personal data

In the following we wish to provide you with information on how we handle your personal data when you use our App. Unless otherwise indicated in the following chapters, the legal basis for the handling of your personal data results from the fact that such handling is required to make available the functionalities of the App as requested by you (Art. 6(1)(b) General Data Protection Regulation).

I.           Using our App

In order to make available to you the services of our App, it will transfer the following data to us, every time you use our App:

  • Email address and Password
  • T&Cs opt in
  • Notes
  • Event date and location/Attendance
  • Questions submitted to speaker
  • Poll/Hotspot/Feedback form responses
  • Number of app views — date and time of last view
  • Number of notes taken, and interactions saved (feedback form/poll answer/questions asked)
  • Content views – date, time and duration

To protect our legitimate interests, we will store such data for a limited period of time in order to be able to initiate a tracking of personal data in the event of actual or attempted unauthorized access to our servers (Art. 6(1)(f) General Data Protection Regulation).

1.          Registration and login

In order to be able to use our App, you will be provided with the password and instructions via email. For this and subsequent login procedure, we collect the following information about you:

We process this personal data in order to provide you with an access to our App and the service therein. They will be deleted in case you deactivate your user account.

We only analyze your use of this App, if we have obtained your prior consent upon your first access to our App (Art. 6(1)(a) General Data Protection Regulation). You may revoke your consent at any time by emailing




2.          Use of the Ask a Question function

You can ask questions during the expert panels via the “ask a question” function. The information you submit via the question function is collected and used exclusively for the purpose of these sessions.

3.          Information on medical side effects and quality complaints

This App is not intended or designed for communications regarding medical side effects, lack of therapeutic effect, medication errors, grey market products/counterfeit medicine, incorrect or off-label use, quality complaints and/or other issues regarding the safety or quality of Bayer products. If you wish to report side effects or make a quality complaint, please contact your health care professional (e.g. physician or pharmacist), your local health authority, or use our Website for the report of undesirable side effects

If you nevertheless report to us undesirable side effects or other issues regarding the safeness or quality of Bayer products, we will be legally bound to deal with your communication and may have to contact you for clarification purposes. Subsequently, we may have to notify the competent health authorities of the issues reported by you. In this context, your information will be forwarded in pseudonymized form, i.e. no information by which you may be directly identified will be passed on. We may also have to forward these pseudonymized notifications to our group companies and cooperation partners, to the extent these are likewise obliged to notify their respectively competent health authorities.

Transfer of data to third parties

We share your data with the following third parties for the following purpose:

Third Party Scope and purpose of transfer Legal grounds
Huntsworth Health PLC Email address and password, T&Cs opt in, Notes (including number), Questions submitted to speaker, poll/feedback form responses and number of interactions saved, number of app views (date and time of last view); Content views – date, time and duration Confirmation of consent, tracking of data, Meeting organization
Duuzra Event Software Ltd Email address and password, T&Cs opt in, Notes (including number), Questions submitted to speaker, poll/feedback form responses and number of interactions saved , number of app views (date and time of last view); Content views – date, time and duration Confirmation of consent, tracking of data, Meeting organization, Analysis of results

B.         Information regarding your rights

The following rights are in general available to you according to applicable data privacy laws:

  • Right of information about your personal data stored by us;
  • Right to request the correction, deletion or restricted processing of your personal data;
  • Right to object to a processing for reasons of our own legitimate interest, public interest, or profiling, unless we are able to proof that compelling, warranted reasons superseding your interests, rights and freedom exist, or that such processing is done for purposes of the assertion, exercise or defense of legal claims;
  • Right to data portability;
  • Right to file a complaint with a data protection authority;
  • You may at any time with future effect revoke your consent to the collection, processing and use of your personal data. For further information please refer to the chapters above describing the processing of data based on your consent.

If you wish to exercise your rights, please address your request to the contact indicated below. (à C.).

C.         Contact

For any questions you may have with respect to data privacy, please write an e-mail to or contact our company data protection officer at the following address:

Bayer Consumer Care AG,

Peter-Merian Strasse 84,

4052 Basel

D.         Amendment of Privacy Statement

We may update our Privacy Statement from time to time. Updates of our Privacy Statement will be published on our App. Any amendments become effective upon publication on our App. We therefore recommend that you regularly visit the site to keep yourself informed on possible updates.



Last updated: 04/04/2018